These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 9516849)
1. Analysis of candidate gene co-amplification with MYCN in neuroblastoma. George RE; Kenyon R; McGuckin AG; Kohl N; Kogner P; Christiansen H; Pearson AD; Lunec J Eur J Cancer; 1997 Oct; 33(12):2037-42. PubMed ID: 9516849 [TBL] [Abstract][Full Text] [Related]
2. Investigation of co-amplification of the candidate genes ornithine decarboxylase, ribonucleotide reductase, syndecan-1 and a DEAD box gene, DDX1, with N-myc in neuroblastoma. United Kingdom Children's Cancer Study Group. George RE; Kenyon RM; McGuckin AG; Malcolm AJ; Pearson AD; Lunec J Oncogene; 1996 Apr; 12(7):1583-7. PubMed ID: 8622876 [TBL] [Abstract][Full Text] [Related]
3. Relationship of DDX1 and NAG gene amplification/overexpression to the prognosis of patients with MYCN-amplified neuroblastoma. Kaneko S; Ohira M; Nakamura Y; Isogai E; Nakagawara A; Kaneko M J Cancer Res Clin Oncol; 2007 Mar; 133(3):185-92. PubMed ID: 17028906 [TBL] [Abstract][Full Text] [Related]
4. Co-amplification of MYCN and a DEAD box gene (DDX1) in primary neuroblastoma. Squire JA; Thorner PS; Weitzman S; Maggi JD; Dirks P; Doyle J; Hale M; Godbout R Oncogene; 1995 Apr; 10(7):1417-22. PubMed ID: 7731693 [TBL] [Abstract][Full Text] [Related]
5. Physical mapping of the DDX1 gene to 340 kb 5' of MYCN. Kuroda H; White PS; Sulman EP; Manohar CF; Reiter JL; Cohn SL; Brodeur GM Oncogene; 1996 Oct; 13(7):1561-5. PubMed ID: 8875996 [TBL] [Abstract][Full Text] [Related]
6. Amplification of Mycn, Ddx1, Rrm2, and Odc1 in rat uterine endometrial carcinomas. Karlsson A ; Helou K; Walentinsson A; Hedrich HJ; Szpirer C; Levan G Genes Chromosomes Cancer; 2001 Aug; 31(4):345-56. PubMed ID: 11433525 [TBL] [Abstract][Full Text] [Related]
7. Amplification of a DEAD box gene (DDX1) with the MYCN gene in neuroblastomas as a result of cosegregation of sequences flanking the MYCN locus. Noguchi T; Akiyama K; Yokoyama M; Kanda N; Matsunaga T; Nishi Y Genes Chromosomes Cancer; 1996 Feb; 15(2):129-33. PubMed ID: 8834177 [TBL] [Abstract][Full Text] [Related]
8. Co-amplification and concomitant high levels of expression of a DEAD box gene with MYCN in human neuroblastoma. Manohar CF; Salwen HR; Brodeur GM; Cohn SL Genes Chromosomes Cancer; 1995 Nov; 14(3):196-203. PubMed ID: 8589036 [TBL] [Abstract][Full Text] [Related]
9. Coamplification of DDX1 correlates with an improved survival probability in children with MYCN-amplified human neuroblastoma. Weber A; Imisch P; Bergmann E; Christiansen H J Clin Oncol; 2004 Jul; 22(13):2681-90. PubMed ID: 15226335 [TBL] [Abstract][Full Text] [Related]
10. The DDX1 gene maps within 400 kbp 5' to MYCN and is frequently coamplified in human neuroblastoma. Amler LC; Schürmann J; Schwab M Genes Chromosomes Cancer; 1996 Feb; 15(2):134-7. PubMed ID: 8834178 [TBL] [Abstract][Full Text] [Related]
11. The neuroblastoma amplified gene, NAG: genomic structure and characterisation of the 7.3 kb transcript predominantly expressed in neuroblastoma. Scott DK; Board JR; Lu X; Pearson AD; Kenyon RM; Lunec J Gene; 2003 Mar; 307():1-11. PubMed ID: 12706883 [TBL] [Abstract][Full Text] [Related]
12. Concomitant DDX1 and MYCN gain in neuroblastoma. Defferrari R; Tonini GP; Conte M; Papio F; Sementa AR; Valent A; Schena F; Perri P; Mazzocco K Cancer Lett; 2007 Oct; 256(1):56-63. PubMed ID: 17611020 [TBL] [Abstract][Full Text] [Related]
13. Genes co-amplified with MYCN in neuroblastoma: silent passengers or co-determinants of phenotype? Scott D; Elsden J; Pearson A; Lunec J Cancer Lett; 2003 Jul; 197(1-2):81-6. PubMed ID: 12880964 [TBL] [Abstract][Full Text] [Related]
14. MYCN oncogene amplification in neuroblastoma is associated with worse prognosis, except in stage 4s: the Italian experience with 295 children. Tonini GP; Boni L; Pession A; Rogers D; Iolascon A; Basso G; Cordero di Montezemolo L; Casale F; Pession A; Perri P; Mazzocco K; Scaruffi P; Lo Cunsolo C; Marchese N; Milanaccio C; Conte M; Bruzzi P; De Bernardi B J Clin Oncol; 1997 Jan; 15(1):85-93. PubMed ID: 8996128 [TBL] [Abstract][Full Text] [Related]
15. Two-dimensional DNA electrophoresis identifies novel CpG islands frequently coamplified with MYCN in neuroblastoma. Wimmer K; Zhu XX; Lamb BJ; Kuick R; Ambros P; Kovar H; Thoraval D; Elkahloun A; Meltzer P; Hanash SM Med Pediatr Oncol; 2001 Jan; 36(1):75-9. PubMed ID: 11464910 [TBL] [Abstract][Full Text] [Related]
16. MYCN-status in neuroblastoma: characteristics of tumours showing amplification, gain, and non-amplification. Spitz R; Hero B; Skowron M; Ernestus K; Berthold F Eur J Cancer; 2004 Dec; 40(18):2753-9. PubMed ID: 15571958 [TBL] [Abstract][Full Text] [Related]
17. MYCN protein expression as a predictor of neuroblastoma prognosis. Chan HS; Gallie BL; DeBoer G; Haddad G; Ikegaki N; Dimitroulakos J; Yeger H; Ling V Clin Cancer Res; 1997 Oct; 3(10):1699-706. PubMed ID: 9815553 [TBL] [Abstract][Full Text] [Related]
18. Correlation of MYCN amplification, Trk-A and CD44 expression with clinical stage in 250 patients with neuroblastoma. Kramer K; Cheung NK; Gerald WL; LaQuaglia M; Kushner BH; LeClerc JM; LeSauter L; Saragovi HU Eur J Cancer; 1997 Oct; 33(12):2098-100. PubMed ID: 9516861 [TBL] [Abstract][Full Text] [Related]
19. Expression of two dead box genes (DDX1 and DDX6) is independent of that of MYCN in human neuroblastoma cell lines. Akiyama K; Akao Y; Yokoyama M; Nakagawa Y; Noguchi T; Yagi K; Nishi Y Biochem Mol Biol Int; 1999 Apr; 47(4):563-8. PubMed ID: 10319407 [TBL] [Abstract][Full Text] [Related]
20. Gene amplification in PNETs/medulloblastomas: mapping of a novel amplified gene within the MYCN amplicon. Frühwald MC; O'Dorisio MS; Rush LJ; Reiter JL; Smiraglia DJ; Wenger G; Costello JF; White PS; Krahe R; Brodeur GM; Plass C J Med Genet; 2000 Jul; 37(7):501-9. PubMed ID: 10882752 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]